NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data Inc. (NASDAQ: CLDA) today announced that its PGxHealth™ division has entered into a non-exclusive sub-license agreement with the Victorian Clinical Genetics Services (VCGS), a not-for-profit subsidiary of the Murdoch Childrens Research Institute, for the provision of genetic testing for familial long QT syndrome (LQTS). The agreement with VCGS covers LQTS testing to individuals and families in Australia and New Zealand. Additional terms were not released.
